128 related articles for article (PubMed ID: 9202678)
1. Coagulation factor abnormalities after the Fontan procedure and its modifications.
Jahangiri M; Shore D; Kakkar V; Lincoln C; Shinebourne E
J Thorac Cardiovasc Surg; 1997 Jun; 113(6):989-92; discussion 992-3. PubMed ID: 9202678
[TBL] [Abstract][Full Text] [Related]
2. Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure.
Cheung EW; Chay GW; Ma ES; Cheung YF
Am J Cardiol; 2005 Dec; 96(11):1571-5. PubMed ID: 16310443
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
[TBL] [Abstract][Full Text] [Related]
4. Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period.
Procelewska M; Kolcz J; Januszewska K; Mroczek T; Malec E
Eur J Cardiothorac Surg; 2007 May; 31(5):866-72. PubMed ID: 17329113
[TBL] [Abstract][Full Text] [Related]
5. Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
Rask O; Hanséus K; Ljung R; Strandberg K; Berntorp E
Cardiol Young; 2009 Apr; 19(2):152-8. PubMed ID: 19195416
[TBL] [Abstract][Full Text] [Related]
6. Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure.
Cheung YF; Chay GW; Chiu CS; Cheng LC
Int J Cardiol; 2005 Jul; 102(3):509-13. PubMed ID: 16004898
[TBL] [Abstract][Full Text] [Related]
7. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion.
Odegard KC; Zurakowski D; DiNardo JA; Castro RA; McGowan FX; Neufeld EJ; Laussen PC
J Thorac Cardiovasc Surg; 2009 Apr; 137(4):934-41. PubMed ID: 19327521
[TBL] [Abstract][Full Text] [Related]
8. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure.
Odegard KC; McGowan FX; Zurakowski D; DiNardo JA; Castro RA; del Nido PJ; Laussen PC
Ann Thorac Surg; 2002 Jun; 73(6):1770-7. PubMed ID: 12078768
[TBL] [Abstract][Full Text] [Related]
9. Ethnic differences in coagulation factor abnormalities after the Fontan procedure.
Cheung YF; Chay GW; Ma ESK
Pediatr Cardiol; 2006; 27(1):96-101. PubMed ID: 16235018
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis and thromboembolic complications in fontan patients: a literature review.
Firdouse M; Agarwal A; Chan AK; Mondal T
Clin Appl Thromb Hemost; 2014 Jul; 20(5):484-92. PubMed ID: 24463598
[TBL] [Abstract][Full Text] [Related]
11. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis.
Odegard KC; McGowan FX; Zurakowski D; Dinardo JA; Castro RA; del Nido PJ; Laussen PC
J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1260-7. PubMed ID: 12830042
[TBL] [Abstract][Full Text] [Related]
12. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations.
Cromme-Dijkhuis AH; Henkens CM; Bijleveld CM; Hillege HL; Bom VJ; van der Meer J
Lancet; 1990 Nov; 336(8723):1087-90. PubMed ID: 1977979
[TBL] [Abstract][Full Text] [Related]
13. Low total, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol levels in patients with complex congenital heart disease after Fontan palliation.
Whiteside W; Tan M; Yu S; Rocchini A
J Pediatr; 2013 Jun; 162(6):1199-204. PubMed ID: 23312682
[TBL] [Abstract][Full Text] [Related]
14. Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients.
Bartz PJ; Driscoll DJ; Dearani JA; Puga FJ; Danielson GK; O'Leary PW; Earing MG; Warnes CA; Hodge DO; Cetta F
J Am Coll Cardiol; 2006 Dec; 48(11):2301-5. PubMed ID: 17161263
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics.
Ohuchi H; Yasuda K; Miyazaki A; Ono S; Hayama Y; Negishi J; Noritake K; Mizuno M; Yamada O
Eur J Cardiothorac Surg; 2015 Mar; 47(3):511-9. PubMed ID: 24699205
[TBL] [Abstract][Full Text] [Related]
16. Specific issues after extracardiac fontan operation: ventricular function, growth potential, arrhythmia, and thromboembolism.
Chowdhury UK; Airan B; Kothari SS; Talwar S; Saxena A; Singh R; Subramaniam GK; Pradeep KK; Patel CD; Venugopal P
Ann Thorac Surg; 2005 Aug; 80(2):665-72. PubMed ID: 16039223
[TBL] [Abstract][Full Text] [Related]
17. Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders.
Cromme-Dijkhuis AH; Hess J; Hählen K; Henkens CM; Bink-Boelkens MT; Eygelaar AA; Bos E
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1126-32. PubMed ID: 8246550
[TBL] [Abstract][Full Text] [Related]
18. Liver and cardiac function in the long term after Fontan operation.
Camposilvan S; Milanesi O; Stellin G; Pettenazzo A; Zancan L; D'Antiga L
Ann Thorac Surg; 2008 Jul; 86(1):177-82. PubMed ID: 18573420
[TBL] [Abstract][Full Text] [Related]
19. Coagulation factor abnormalities after the Fontan procedure and its modifications.
Sluysmans T; Ovaert C; d'Udekem Y; Barrea C
J Thorac Cardiovasc Surg; 1999 May; 117(5):1038. PubMed ID: 10336350
[No Abstract] [Full Text] [Related]
20. Clinical outcome of patients 20 years after Fontan operation--effect of fenestration on late morbidity.
Ono M; Boethig D; Goerler H; Lange M; Westhoff-Bleck M; Breymann T
Eur J Cardiothorac Surg; 2006 Dec; 30(6):923-9. PubMed ID: 17074498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
